122 related articles for article (PubMed ID: 7026250)
1. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
[No Abstract] [Full Text] [Related]
2. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
Pierpont GL; Cohn JN; Franciosa JA
Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
[No Abstract] [Full Text] [Related]
3. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
4. Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.
Elkayam U; Weber L; McKay CR; Rahimtoola SH
Am J Cardiol; 1984 Jul; 54(1):126-31. PubMed ID: 6741802
[TBL] [Abstract][Full Text] [Related]
5. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
Kittleson MD; Johnson LE; Oliver NB
J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
8. Hydralazine in the management of left ventricular failure.
Fitchett DH; Neto JA; Oakley CM; Goodwin JF
Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
[No Abstract] [Full Text] [Related]
9. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
Haitas B; Meyer TE; Angel ME; Reef E
Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Massie BM; Packer M; Hanlon JT; Combs DT
J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
[No Abstract] [Full Text] [Related]
12. Sustained effect of hydralazine in long term treatment of CHF.
Conradson TB; Rydén L
Acta Med Scand Suppl; 1981; 652():173-6. PubMed ID: 6800217
[No Abstract] [Full Text] [Related]
13. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
[TBL] [Abstract][Full Text] [Related]
14. Oral hydralazine therapy for chronic refractory heart failure.
Chatterjee K; Parmley WW; Massie B; Greenberg B; Werner J; Klausner S; Norman A
Circulation; 1976 Dec; 54(6):879-83. PubMed ID: 825327
[TBL] [Abstract][Full Text] [Related]
15. Hydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses.
Magorien RD; Unverferth DV; Leier CV
Am J Med; 1984 Aug; 77(2):267-74. PubMed ID: 6431812
[TBL] [Abstract][Full Text] [Related]
16. Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.
Figueras J; Taylor WR; Ogawa T; Forrester JS; Singh BN; Swan HJ
Br Heart J; 1979 Mar; 41(3):317-24. PubMed ID: 371647
[No Abstract] [Full Text] [Related]
17. Acute hemodynamic effects of endralazine: a new vasodilator for chronic refractory congestive heart failure.
Quyyumi AA; Wagstaff D; Evans TR
Am J Cardiol; 1983 May; 51(8):1353-7. PubMed ID: 6846162
[TBL] [Abstract][Full Text] [Related]
18. Precipitation of heart failure following sudden withdrawal of hydralazine.
Black JR; Mehta J
Chest; 1979 Jun; 75(6):724-5. PubMed ID: 436528
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension.
Groves BM; Rubin LJ; Frosolono MF; Cato AE; Reeves JT
Am Heart J; 1985 Dec; 110(6):1200-4. PubMed ID: 3907315
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine in chronic CHF.
Chatterjee K; Rouleau JL; Massie BM
Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
